$11 Million Boost For Regional NSW Cancer Research
Major funding will expand regional research careers and bring more cancer trials within reach of rural patients. New…
Effects of Pharmacological and Surgical Treatments on Mitral Regurgitation Regression and Left Heart Structures: A Meta-Analysis
https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2026.0024Newswise — Announcing a new article publication for Cardiovascular Innovations and Applications journal providing fresh evidence on the effectiveness of…
Asthma Antiviral Nasal Spray Secures Funding for Clinical Trial
A new study will evaluate whether a weekly dry powder nasal spray can boost natural defenses and prevent…
You Want To Join a Clinical Trial. Here’s What To Know About the Hurdles.
Connecting people with clinical trials is complicated — even if people identify a promising match, there’s a slew…
Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study
Adult B-ALL exhibits significant heterogeneity and poor prognosis compared with the pediatric population. While the complete remission (CR)…
Newly Identified Inhibitors May Boost Chemotherapy Drug’s Ability to Fight Treatment-Resistant Cancers
Newswise — In a new report of research, scientists at Johns Hopkins University School of Medicine and Johns…
TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia
TG Therapeutics, Inc. Phase 2 trial to evaluate the effects of B-cell depletion with BRIUMVI in approximately 60…
3 Companies Redefining Healthcare Innovation
This article was originally published on ETFTrends.com. The Healthcare Technology and Innovation index (HTEC) was launched back in…
Definium LSD therapy for major depression helped patients in Phase 3 trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus
Eledon Pharmaceuticals, Inc. Tegoprubart-treated patients maintained higher mean eGFR over time, including a statistically significant approximately 12 mL/min/1.73…
TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial
TG Therapeutics, Inc. 82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement…
The Supplement That Science Says Could Make the World Less Angry
If you found out a supplement existed that could lower aggression, you would probably think it was something…